Geneos Wealth Management’s United States Antimony UAMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $41.2K | Hold |
9,892
| – | – | ﹤0.01% | 1775 |
|
|
2026
Q2 | $71.8K | Hold |
9,892
| – | – | ﹤0.01% | 1342 |
|
|
2026
Q1 | $86.4K | Buy |
9,892
+1,500
| +18% | +$13.1K | ﹤0.01% | 1221 |
|
|
2025
Q4 | $42.1K | Buy |
8,392
+521
| +7% | +$4.09K | ﹤0.01% | 1458 |
|
|
2025
Q3 | $48.8K | Buy |
+7,871
| New | +$32.9K | ﹤0.01% | 1395 |
|
|
2023
Q1 | – | Sell |
-25,300
| Closed | -$12.4K | – | 2100 |
|
|
2022
Q4 | $12.4K | Hold |
25,300
| – | – | ﹤0.01% | 1473 |
|
|
2022
Q3 | $9K | Sell |
25,300
-25,000
| -50% | -$10.9K | ﹤0.01% | 1556 |
|
|
2022
Q2 | $20K | Hold |
50,300
| – | – | ﹤0.01% | 1689 |
|
|
2022
Q1 | $32K | Sell |
50,300
-315
| -0.6% | -$154 | ﹤0.01% | 1578 |
|
|
2021
Q4 | $25K | Hold |
50,615
| – | – | ﹤0.01% | 1779 |
|
|
2021
Q3 | $44K | Buy |
50,615
+25,300
| +100% | +$23.3K | ﹤0.01% | 1552 |
|
|
2021
Q2 | $24K | Hold |
25,315
| – | – | ﹤0.01% | 1828 |
|
|
2021
Q1 | $23K | Hold |
25,315
| – | – | ﹤0.01% | 2015 |
|
|
2020
Q4 | $28K | Sell |
25,315
-44,685
| -64% | -$18.2K | ﹤0.01% | 1735 |
|
|
2020
Q3 | $21K | Hold |
70,000
| – | – | ﹤0.01% | 1640 |
|
|
2020
Q2 | $35K | Hold |
70,000
| – | – | ﹤0.01% | 1378 |
|
|
2020
Q1 | $24K | Hold |
70,000
| – | – | ﹤0.01% | 1437 |
|
|
2019
Q4 | $27K | Hold |
70,000
| – | – | ﹤0.01% | 1566 |
|
|
2019
Q3 | $38K | Sell |
70,000
-18,000
| -20% | -$11.7K | ﹤0.01% | 1317 |
|
|
2019
Q2 | $49K | Hold |
88,000
| – | – | ﹤0.01% | 1204 |
|
|
2019
Q1 | $41K | Hold |
88,000
| – | – | ﹤0.01% | 1240 |
|
|
2018
Q4 | $52K | Hold |
88,000
| – | – | ﹤0.01% | 1082 |
|
|
2018
Q3 | $75K | Sell |
88,000
-122,000
| -58% | -$73.5K | 0.01% | 990 |
|
|
2018
Q2 | $100K | Sell |
210,000
-22,000
| -9% | -$7.29K | 0.01% | 785 |
|
|
2018
Q1 | $58K | Sell |
232,000
-36,000
| -13% | -$10.7K | 0.01% | 944 |
|
|
2017
Q4 | $85K | Sell |
268,000
-145,000
| -35% | -$38.1K | 0.01% | 803 |
|
|
2017
Q3 | $119K | Sell |
413,000
-47,000
| -10% | -$15.5K | 0.01% | 648 |
|
|
2017
Q2 | $179K | Sell |
460,000
-10,000
| -2% | -$4.2K | 0.02% | 524 |
|
|
2017
Q1 | $232K | Hold |
470,000
| – | – | 0.02% | 443 |
|
|
2016
Q4 | $117K | Hold |
470,000
| – | – | 0.02% | 573 |
|
|
2016
Q3 | $211K | Hold |
470,000
| – | – | 0.03% | 435 |
|
|
2016
Q2 | $96K | Hold |
470,000
| – | – | 0.01% | 603 |
|
|
2016
Q1 | $112K | Buy |
+470,000
| New | +$116K | 0.02% | 554 |
|
Other funds holding UAMY
Geneos Wealth Management's UAMY Position: Q3 2026 in Review
Geneos Wealth Management held its United States Antimony (UAMY) position steady in Q3 2026 at 9,892 shares worth $41.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1775.
Geneos Wealth Management first reported a position in UAMY in Q1 2016 and has held it in 33 quarters since. The position peaked at $232K in Q1 2017. 123 funds tracked by Wall St. Rank hold UAMY as of Q3 2026.
- Geneos Wealth Management held 9,892 shares of United States Antimony worth $41.2K as of Q3 2026.
- Geneos Wealth Management left its United States Antimony share count unchanged in Q3 2026.
- United States Antimony made up ﹤0.01% of Geneos Wealth Management's portfolio in Q3 2026, its #1775 holding.
- Geneos Wealth Management first reported a position in United States Antimony in Q1 2016 and has held it in 33 quarters since.
- Geneos Wealth Management's United States Antimony position peaked at $232K in Q1 2017.
- 123 funds tracked by Wall St. Rank held United States Antimony as of Q3 2026.
Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.